NU-6300

• Description:

  NU-6300 is the first covalent, irreversible, ATP-Competitive CDK2 inhibitor with Ki of 6 nM.

• Stability:

  ≥ 2 years

• Purity:

  >98% (HPLC)

• Weight:

  413.4933

• Molecular Formula:

  C20H23N5O3S

• Notes:

  Research use only, not for human use.

• Receptor:

  CDK

• CAS Number:

  2070015-09-5